References
American Cancer Society. (2006b). Cancer prevention and early detection facts and figures. Atlanta, GA: Author.
American College of Preventive Medicine. (2005). Screening asymptomatic women for ovarian cancer: American College of Preventive Medicine practice policy statement. Retrieved November 29, 2007, 2007, from
http://www.acpm.org/ovary.htm
American Society of Clinical Oncology. (1996). Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility, adopted on February 20, 1996. Journal of Clinical Oncology, 14(5), 1730-1740.
American Society of Clinical Oncology. (2003). American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. Journal of Clinical Oncology, 21(12), 2397-2406.
American Society of Human Genetics. (1994). Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. American Journal of Human Genetics, 55(5), i-iv.
Andrieu, N., Easton, D. F., Chang-Claude, J., Rookus, M. A., Brohet, R., Cardis, E., et al. (2006). Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. Journal of Clinical Oncology, 24(21), 3361-3366.
Botkin, J. R., Smith, K. R., Croyle, R. T., Baty, B. J., Wylie, J. E., Dutson, D., et al. (2003). Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics, 118A(3), 201-209.
Braithwaite, D., Emery, J., Walter, F., Prevost, A. T., & Sutton, S. (2006). Psychological impact of genetic counseling for familial cancer: A systematic review and meta-analysis. Familial Cancer, 5(1), 61-75.
Brekelmans, C. T., Seynaeve, C., Bartels, C. C., Tilanus-Linthorst, M. M., Meijers-Heijboer, E. J., Crepin, C. M., et al. (2001). Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. Journal of Clinical Oncology, 19(4), 924-930.
Burke, W. (2002). Genetic testing. New England Journal of Medicine, 347(23), 1867-1875.
Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M. J., Lynch, P., et al. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA, 277(12), 997-1003.
Claes, E., Evers-Kiebooms, G., Decruyenaere, M., Denayer, L., Boogaerts, A., Philippe, K., et al. (2005). Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer. Behavioral Medicine, 31(3), 93-105.
Couch, F. J., DeShano, M. L., Blackwood, M. A., Calzone, K., Stopfer, J., Campeau, L., et al. (1997). BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. New England Journal of Medicine, 336(20), 1409-1415.
Daly, M. B. (2004). Tailoring breast cancer treatment to genetic status: The challenges ahead. Journal of Clinical Oncology, 22(10), 1776-1777.
Donovan, H. S., Hartenbach, E. M., & Method, M. W. (2005). Patient-provider communication and perceived control for women experiencing multiple symptoms associated with ovarian cancer. Gynecologic Oncology, 99(2), 404-411.
Dorval, M., Gauthier, G., Maunsell, E., Dugas, M. J., Rouleau, I., Chiquette, J., et al. (2005). No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result. Cancer Epidemiology, Biomarkers and Prevention, 14(2), 2862-2867.
Easton, D. F., Hopper, J. L., Thomas, D. C., Antoniou, A., Pharoah, P. D., Whittemore, A. S., et al. (2004). Breast cancer risks for BRCA1/2 carriers. Science, 306(5705), 2187-2191.
Emmons, K. M., Kalkbrenner, K. J., Klar, N., Light, T., Schneider, K. A., & Garber, J. E. (2000). Behavioral risk factors among women presenting for genetic testing. Cancer Epidemiology, Biomarkers and Prevention, 9(1), 89-94.
Esserman, L., & Hylton, N. (2005). The Gundry article reviewed. Oncology, 19(2), 170-174.
Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B., et al. (2002). Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10,000 individuals. Journal of Clinical Oncology, 20(6), 1480-1490.
Gayther, S. A., Russell, P., Harrington, P., Antoniou, A. C., Easton, D. F., & Ponder, B. A. (1999). The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: No evidence for other ovarian cancer-susceptibility genes. American Journal of Human Genetics, 65(4), 1021-1029.
Ghosh, K., Hartmann, L., & Brandt, K. R. (2004). The Wood article reviewed. Oncology, 18(1), 39-42.
Gundry, K. R. (2005). The application of breast MRI in staging and screening for breast cancer. Oncology, 19(2), 159-169.
Isaacs, C., Peshkin, B. N., Schwartz, M., Demarco, T. A., Main, D., & Lerman, C. (2002). Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Research and Treatment, 71(2), 103-112.
Kash, K. M., Holland, J. C., Halper, M. S., & Miller, D. G. (1992). Psychological distress and surveillance behaviors of women with a family history of breast cancer. Journal of the National Cancer Institute, 84(1), 24-30.
Kauff, N. D., Mitra, N., Robson, M. E., Hurley, K. E., Chuai, S., Goldfrank, D., et al. (2005). Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families. Journal of the National Cancer Institute, 97(18), 1382-1384.
King, M. C., Marks, J. H., & Mandell, J. B. (2003). Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science, 302(5645), 643-646.
Kinney, A. Y., Hicken, B., Simonsen, S. E., Venne, V., Lowstuter, K., Balzotti, J., et al. (2007). Colorectal cancer surveillance behaviors among members of typical and attenuated FAP families. American Journal of Gastroenterology, 102(1), 153-162.
Kuschel, B., Lux, M. P., Goecke, T. O., & Beckmann, M. W. (2000). Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer. European Journal of Cancer Prevention, 9(3), 139-150.
Lerman, C., Daly, M., Sands, C., Balshem, A., Lustbader, E., Heggan, T., et al. (1993). Mammography adherence and psychological distress among women at risk for breast cancer. Journal of the National Cancer Institute, 85(13), 1074-1080.
Lerman, C., Hughes, C., Croyle, R. T., Main, D., Durham, C., Snyder, C., et al. (2000). Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Preventive Medicine, 31, 75-80.
Lerman, C., Lustbader, E., Rimer, B., Daly, M., Miller, S., Sands, C., et al. (1995). Effects of individualized breast cancer risk counseling: A randomized trial. Journal of the National Cancer Institute, 87(4), 286-292.
Lynch, H. T., & Lynch, J. F. (1991). Familial factors and genetic predisposition to cancer: Population studies. Cancer Detection and Prevention, 15(1), 49-57.
MacDonald, D. J. (2002). Women's decisions regarding management of breast cancer risk. MedSurg Nursing, 11(4), 183-186.
MacDonald, D. J., Sarna, L., Uman, G. C., Grant, M., & Weitzel, J. N. (2006). Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers [Online exclusive].
Oncology Nursing Forum, 33(2), E27-E35. Retrieved February 6, 2009, from
http://ons.metapress.com/content/h307166720r5525q/?p=0b0715b62e524d36a2… http://ons.metapress.com/content/h307166720r5525q/?p=0b0715b62e524d36a22efb7225bfae3a&pi=0
Madjar, H., Rickard, M., Jellins, J., & Otto, R. (1999). IBUS guidelines for the ultrasonic examination of the breast. IBUS International Faculty. International Breast Ultrasound School. European Journal of Ultrasound, 9(1), 99-102.
Madlensky, L., Vierkant, R. A., Vachon, C. M., Pankratz, V. S., Cerhan, J. R., Vadaparampil, S. T., et al. (2005). Preventive health behaviors and familial breast cancer. Cancer Epidemiology, Biomarkers and Prevention, 14(10), 2340-2345.
McInerney-Leo, A., Hadley, D., Kase, R. G., Giambarresi, T. R., Struewing, J. P., & Biesecker, B. B. (2006). BRCA1/2 testing in hereditary breast and ovarian cancer families III: Risk perception and screening. American Journal of Medical Genetics, 140(20), 2198-2206.
Oldenburg, R. A., Meijers-Heijboer, H., Cornelisse, C. J., & Devilee, P. (2007). Genetic susceptibility for breast cancer: How many more genes to be found? Critical Reviews in Oncology/Hematology, 63(2), 125-149.
Petrucelli, N., Daly, M. B., Bars Culver, J. O., Levy-Lahad, E., & Feldman, G. L. (2005). BRCA1 and BRCA2 hereditary breast/ovarian cancer. Retrieved January 8, 2008, from
http://www.geneclinics.org/servlet/access?db=geneclinics&site=gt&id=8888891&key=StY9BaIVS9ayW&gry=&fcn=y&fw=ZsLL&filename=/profiles/brca1/index.html
Pisano, E. D., Gatsonis, C., Hendrick, E., Yaffe, M., Baum, J. K., Acharyya, S., et al. (2005). Diagnostic performance of digital versus film mammography for breast-cancer screening. New England Journal of Medicine, 353(17), 1773-1783.
Ray, J. A., Loescher, L. J., & Brewer, M. (2005). Risk-reduction surgery decisions in high-risk women seen for genetic counseling. Journal of Genetic Counseling, 14(6), 473-484.
Rogozinska-Szczepka, J., Utracka-Hutka, B., Grzybowska, E., Maka, B., Nowicka, E., Smok-Ragankiewicz, A., et al. (2004). BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients. Annals of Oncology, 15(9), 1373-1376.
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., et al. (2007). American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA: A Cancer Journal for Clinicians, 57(2), 75-89.
Scheuer, L., Kauff, N., Robson, M., Kelly, B., Barakat, R., Satagopan, J., et al. (2002). Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of Clinical Oncology, 20(5), 1260-1268.
Schwartz, M. D., Peshkin, B. N., Hughes, C., Main, D., Isaacs, C., & Lerman, C. (2002). Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. Journal of Clinical Oncology, 20(2), 514-520.
Sifri, R., Gangadharappa, S., & Acheson, L. S. (2004). Identifying and testing for hereditary susceptibility to common cancers. CA: A Cancer Journal for Clinicians, 54(6), 309-326.
Smith, A., Moran, A., Boyd, M. C., Bulman, M., Shenton, A., Smith, L., et al. (2007). Phenocopies in BRCA1 and BRCA2 families: Evidence for modifier genes and implications for screening. Journal of Medical Genetics, 44(1), 10-15.
Smith, R. A., Saslow, D., Sawyer, K. A., Burke, W., Costanza, M. E., Evans, W. P., III, et al. (2003). American Cancer Society guidelines for breast cancer screening: Update 2003. CA: A Cancer Journal for Clinicians, 53(3), 141-169.
Thull, D. L., & Vogel, V. G. (2004). Recognition and management of hereditary breast cancer syndromes. Oncologist, 9(1), 13-24.
Warner, E., Plewes, D. B., Hill, K. A., Causer, P. A., Zubovits, J. T., Jong, R. A., et al. (2004). Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA, 292(11), 1317-1325.
Watson, P., Butzow, R., Lynch, H. T., Mecklin, J. P., Jarvinen, H. J., Vasen, H. F., et al. (2001). The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecologic Oncology, 82(2), 223-228.
Weitzel, J. N., McCaffrey, S. M., Nedelcu, R., MacDonald, D. J., Blazer, K. R., & Cullinane, C. A. (2003). Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Archives of Surgery, 138(12), 1323-1328.
Wood, W. C. (2004). Advising women at high risk of breast cancer. Oncology, 18(1), 28-32.
Yusoff, I. F., Hoffman, N. E., & Ee, H. C. (2002). Colonoscopic surveillance for family history of colorectal cancer: Are NHMRC guidelines being followed? Medical Journal of Australia, 176(4), 151-154.